• Home
  • Top News
  • Press Room
  • International Exchanges
  • White Papers
  • Videos
  • Featured
    • Belt and Road
    • Xinjiang Focus
  • About SCIO
  • China Facts
Home - Policy briefing on Opinions on Promoting Regular and Regulated Volume-based Procurement of Pharmaceuticals - Highlights - 
  • Bulk government purchases halve drug prices in China

    China's centralized drug bulk-buying program has helped slash the prices of 112 varieties of medicine by an average of 54 percent, the National Healthcare Security Administration said on Friday.

    January 30, 2021
  • China issues guidelines to boost centralized drug bulk-buying

    China has issued a set of guidelines to push forward the country's centralized drug bulk-buying program in a bid to make it a regular and institutionalized practice.

    January 29, 2021
  • China to advance reform of centralized drug bulk-buying

    China will take a step forward in its centralized drug bulk-buying program, and make it a regular and institutionalized practice to lower medical costs for the general public, the State Council executive meeting chaired by Premier Li Keqiang decided on Friday.

    January 16, 2021
  • China's centralized procurement leads to 50% drop in prices of over 100 drugs

    Three rounds of the Chinese government's centralized drug-procurement program over the past two years have seen 112 varieties of medicine selected, with the average price down by 54 percent, a National Healthcare Security Administration official said on Friday.

    November 20, 2020